About BARDA DRIVe
BARDA DRIVe is a Healthcare company. Innovative health security solutions are funded by BARDA DRIVe. It operates on a Professional Services model. BARDA DRIVe offers products and services including TyPe (Therapeutic Efficacy through Predicting Treatment Response), IMMUNECHIP+, and Influenza Vaccine Innovation. Its focus areas include Biotechnology and Health Security Innovation.
Company details
Early-stage companies are supported by BARDA DRIVe for life-saving innovations in health security. Focus is placed on breakthrough devices and technologies to tackle major health threats. Programs such as therapeutic efficacy, vaccine delivery, and diagnostics are funded across various sectors. A network of accelerators is launched to streamline processes and support new technologies. The approach is modeled on entrepreneurial best practices to address health security challenges.
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Website drive.hhs.gov
Products & Services of BARDA DRIVe
BARDA DRIVe offers a comprehensive portfolio of products and services, including TyPe (Therapeutic Efficacy through Predicting Treatment Response), IMMUNECHIP+, and Influenza Vaccine Innovation.
Patient stratification products are developed for therapeutic efficacy.
3D human tissue models are enhanced for drug development.
Effective influenza vaccines are developed for future pandemics.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about BARDA DRIVe
Early-stage companies are supported by BARDA DRIVe for life-saving innovations in health security. Focus is placed on breakthrough devices and technologies to tackle major health threats. Programs such as therapeutic efficacy, vaccine delivery, and diagnostics are funded across various sectors. A network of accelerators is launched to streamline processes and support new technologies. The approach is modeled on entrepreneurial best practices to address health security challenges.
BARDA DRIVe offers TyPe (Therapeutic Efficacy through Predicting Treatment Response), IMMUNECHIP+, and Influenza Vaccine Innovation.
